Funding sources for the study: NasoNeb.
A pilot study of the effects of intranasal budesonide delivered by NasoNeb® on patients with perennial allergic rhinitis
Version of Record online: 8 NOV 2013
© 2013 ARS-AAOA, LLC
International Forum of Allergy & Rhinology
Volume 4, Issue 1, pages 43–48, January 2014
How to Cite
How to Cite this Article: A pilot study of the effects of intranasal budesonide delivered by NasoNeb® on patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2014;4:43-48., , , , , .
Potential conflict of interest: None provided.
Public clinical trial registration: http://clinicaltrials.gov/show/NCT01270256. Evaluation of NasoNeb™ Delivery of an Intranasal Steroid in the Treatment of Perennial Allergic Rhinitis.
- Issue online: 2 JAN 2014
- Version of Record online: 8 NOV 2013
- Manuscript Revised: 24 AUG 2013
- Manuscript Accepted: 18 JUN 2013
- Manuscript Received: 18 MAR 2013
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!